Table 2 Results of telephone monitoring and administration of 5-item-questionnaire, echocardiography, cardiopulmonary exercise testing and further evaluation confirming CTEPH
Visit 1, 3 months | Visit 2, 6 months | Visit 3, 12 months | |
|---|---|---|---|
N(%) | N(%) | N(%) | |
Telephone calls | 130 | 102 | 58 |
5-Item-Questionnaire positiv | 49 (37.7%) | 26 (25.5%) | 17 (29,3%) |
Outpatient visits | 49 | 26 | 17 |
Echocardiography, | n = 49 | n = 26 | n = 16 |
RVSP >/=35 mm Hg | 10 (20.4%) | 3 (11.5%) | 3 (18.8%) |
REVSP < 35 mm Hg/ not detectable | 39 (79.6%) | 23 (88.5%) | 13 (81.25%) |
Cardiopulmonary exercise testing, | n = 34 | n = 15 | n = 9 |
Abnormal pulmonary perfusion suspected | 12 (35.28%) | 4 (26.7%) | 1 (11.1%) |
Further evaluation | 21 | 7 | 4 |
CTEPH/CTPVD proven per visit | 5(3.85)/2(1.5%) | 3(2.94/1(0.98%) | 0/0.0%) |
CTEPH/CTPVD proven, all patients | 5(3.85%)/2(1.5%) | 8(6.2%)/3(2.3%) | 8(6.2%)/3(2.3%) |